secwatch.observer — SEC 8-K summary
======================================

Issuer:     VivoSim Labs, INC. (VIVS)
CIK:        0001497253
Form:       8-K
Filed at:   2024-05-01T23:59:59+00:00
Accession:  0000950170-24-050906
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Organovo furnishes May 2024 corporate presentation; no specific financial data disclosed
--------------------------------------------------------------------------------

- Company posted investor presentation on its website covering business overview and strategy.
- Presentation includes forward-looking statements and is current as of May 1, 2024.
- No material new information such as earnings, guidance, or clinical milestones were disclosed in the excerpt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1497253/000095017024050906/0000950170-24-050906-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1497253/000095017024050906/onvo-20240501.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-050906

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer